$48.32
0.60% yesterday
Nasdaq, Dec 23, 10:08 pm CET
ISIN
US80105N1054
Symbol
SNY

Sanofi Sponsored ADR Stock price

$48.32
-0.83 1.69% 1M
+0.14 0.29% 6M
+0.09 0.19% YTD
-0.07 0.14% 1Y
-0.20 0.41% 3Y
+0.74 1.56% 5Y
+4.54 10.37% 10Y
+3.12 6.90% 20Y
Nasdaq, Closing price Tue, Dec 23 2025
+0.29 0.60%
ISIN
US80105N1054
Symbol
SNY
Industry

Key metrics

Basic
Market capitalization
$116.5b
Enterprise Value
$131.7b
Net debt
$15.2b
Cash
$10.5b
Shares outstanding
1.2b
Valuation (TTM | estimate)
P/E
3.6 | 5.2
P/S
1.5 | 2.2
EV/Sales
1.7 | 2.5
EV/FCF
-
P/B
1.4
Dividends
DPS
$2.20
Yield 1Y | 5Y
4.5% | 4.0%
Growth 1Y | 5Y
7.8% | 5.3%
Payout 1Y | 3Y
39.1% | 32.3%
Increased
2 Years
Financials (TTM | estimate)
Revenue
$78.9b | $53.5b
EBITDA
$21.4b | $16.4b
EBIT
$18.6b | $13.5b
Net Income
$16.3b | $11.4b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
21.8% | 2.5%
EBITDA
23.1% | 31.8%
EBIT
27.6% | 31.3%
Net Income
102.8% | 73.2%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
72.3%
EBITDA
27.1% | 30.6%
EBIT
23.6%
Net
20.6% | 21.2%
Free Cash Flow
-
Financial Health
Equity Ratio
58.4%
Return on Equity
7.2%
ROCE
16.2%
ROIC
13.0%
Debt/Equity
0.3
More
EPS
$13.4
FCF per Share
-
Short interest
0.3%
Employees
83k
Rev per Employee
$630.0k
Show more

Is Sanofi Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,085 stocks worldwide.

Sanofi Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Sanofi Sponsored ADR forecast:

23x Buy
79%
5x Hold
17%
1x Sell
3%

Analyst Opinions

29 Analysts have issued a Sanofi Sponsored ADR forecast:

Buy
79%
Hold
17%
Sell
3%

Financial data from Sanofi Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
78,913 78,913
22% 22%
100%
- Direct Costs 21,865 21,865
11% 11%
28%
57,048 57,048
26% 26%
72%
- Selling and Administrative Expenses 15,265 15,265
14% 14%
19%
- Research and Development Expense 13,363 13,363
36% 36%
17%
21,374 21,374
23% 23%
27%
- Depreciation and Amortization 2,742 2,742
1% 1%
3%
EBIT (Operating Income) EBIT 18,632 18,632
28% 28%
24%
Net Profit 16,277 16,277
103% 103%
21%

In millions USD.

Don't miss a Thing! We will send you all news about Sanofi Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanofi Sponsored ADR Stock News

Positive
Investors Business Daily
about one hour ago
Sanofi will buy vaccine maker Dynavax Technologies for $2.2 billion, or $15.50 a share, adding to its adult immunizations. Dynavax stock soared.
Positive
Reuters
about 5 hours ago
French drugmaker Sanofi has entered into an agreement to acquire U.S. vaccines company Dynavax Technologies Corporation for around $2.2 billion (1.87 billion euros), it said on Wednesday.
Positive
WSJ
about 6 hours ago
The cash deal seeks to strengthen the French drugmaker's immunization portfolio after it suffered setbacks in clinical trials.
More Sanofi Sponsored ADR News

Company Profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Head office France
CEO Paul Hudson
Employees 82,878
Founded 1994
Website www.sanofi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today